This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jim Cramer's 'Mad Money' Recap: A Monster of an August

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK ( TheStreet) -- With the market near completing its best August in 14 years, Jim Cramer told his Mad Money viewers Tuesday there's not much to fear at these levels but there is still a lot to embrace.

Just how did the market achieve such remarkable gains? Cramer said that Monster Beverage (MNST) helped with its 36% gain and he would still be a buyer of the stock. Likewise with Mohawk Industries (MHK) and Gilead Sciences (GILD) , which were up 17% and 16%, respectively. Cramer said he's a fan of both companies, especially Gilead, which still trades at just 11 times earnings.

Read More: 10 Stocks Carl Icahn Loves in 2014

Cramer said he's also a fan of Ross Stores (ROST) and Gap Stores (GPS) , both of which are gaining steam as gas prices continue to fall.

Cramer is less enthusiastic about Dollar General's (DG) 15% gain for the month, saying that some of those gains will likely be given back in the coming weeks.

Other big winners for August included Tenet Healthcare (THC) and Keurig Green Mountain (GMCR) , along with Netflix (NFLX) , Southwest Airlines (LUV) , Masco (MAS) and Home Depot (HD) .

Finally, Cramer said he's a fan of Kinder Morgan (KMI) , a stock which he's buying for his charitable trust, Action Alerts PLUS.

Is Perrigo a Bargain?

Are there still bargains to be had with the markets at record highs? Cramer said there are if investors are considering private label drug maker Perrigo (PRGO) , a stock that's up 226% since he first got behind the stock four years ago.

After peaking in March, shares of Perrigo have declined due to manufacturing issues that lowered the company's earnings. But now that those issues are in the past, Cramer said this fantastic company should be ready to resume going higher.

Cramer said Perrigo products simply make sense for thrifty consumers. Why pay over $71 for a box of Nicorette gum, for example, when the identical Perrigo product sells for 26% less? Perrigo is a lot more than just over-the-counter medications -- it makes generic drugs and nutritional supplements.

With so many prescription drugs coming off patent in the coming years, Cramer said Perrigo will have no shortage of new products. The company will introduce 75 products this year alone.

Read More: Warren Buffett’s Latest Whopper of a Yield Deal

Beyond its new product innovations, Cramer said Perrigo's newfound Irish tax status will also help boost earnings power and make the company an attractive takeover target for other companies looking for a tax inversion. Cramer said he sees Perrigo shares hitting $175 a share by the end of the year.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs